Covalent HLA-B27/peptide complex induced by specific recognition of an aziridine mimic of arginine.

AUTOR(ES)

Weiss, G A

RESUMO

The class I major histocompatibility complex (MHC) glycoprotein HLA-B27 binds short peptides containing arginine at peptide position 2 (P2). The HLA-B27/peptide complex is recognized by T cells both as part of the development of the repertoire of T cells in the cellular immune system and during activation of cytotoxic T cells. Based on the three-dimensional structure of HLA-B27, we have synthesized a ligand with an aziridine-containing side chain designed to mimic arginine and to bind covalently in the arginine-specific P2 pocket of HLA-B27. Using tryptic digestion followed by mass spectrometry and amino acid sequencing, the aziridine-containing ligand is shown to alkylate specifically cysteine 67 of HLA-B27. Neither free cysteine in solution nor an exposed cysteine on a class II MHC molecule can be alkylated, showing that specific recognition between the anchor side-chain pocket of an MHC class I protein and the designed ligand (propinquity) is necessary to induce the selective covalent reaction with the MHC class I molecule.

Documentos Relacionados

• HLA-B*27 typing by sequence specific amplification without DNA extraction.
• The ramifications of HLA-B27
• Heart conduction disturbance: an HLA-B27 associated disease.
• Seasonal variation of acute anterior uveitis: differences between HLA-B27 positive and HLA-B27 negative disease.
• Absence of a specific effect of free radicals on HLA-B27.